Kuros Biosciences AG (KURN) — Capital Reinvestment Ratio
Latest as of December 2025:
0.53x
Kuros Biosciences AG (KURN) has a Capital Reinvestment Ratio of 0.53x as of December 2025, meaning it reinvests 1% of its operating cash flow (CHF1.94 Million) in capital expenditures (CHF1.03 Million). See KURN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.53x
Capex / Operating Cash Flow
Operating Cash Flow
CHF1.94 Million
CHF
Capital Expenditures
CHF1.03 Million
CHF
Data as of
Dec 2025
Most recent filing
Kuros Biosciences AG Capital Reinvestment Ratio (2024–2024)
This chart tracks Kuros Biosciences AG's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Kuros Biosciences AG (2024–2024)
Year-by-year Capital Reinvestment Ratio for Kuros Biosciences AG from 2024 to 2024. For live market cap and broader valuation context, see how much is Kuros Biosciences AG worth.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.35x | CHF3.14 Million | CHF1.11 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow